Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.776,28
-0,18%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Lyell Immunopharma Inc (LYEL) Lyell Immunopharma Inc (LYEL) Notizie

Lyell Immunopharma Inc

LYEL
2,36
-0,04 (-1,67%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/3/202422:30GLOBELyell Immunopharma Announces the Acceptance of Three..
28/2/202422:07EDGAR2Form 8-K - Current report
28/2/202422:05GLOBELyell Immunopharma Reports Business Highlights and Financial..
26/2/202422:05GLOBELyell Immunopharma Announces Participation in March Investor..
14/2/202402:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202402:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202402:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:05GLOBELyell Immunopharma to Participate in 42nd Annual J.P. Morgan..
21/11/202302:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202302:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202302:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202322:26EDGAR2Form 8-K - Current report
09/11/202322:05GLOBELyell Immunopharma Receives FDA Orphan Drug Designation for..
07/11/202322:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:08EDGAR2Form 8-K - Current report
07/11/202322:05GLOBELyell Immunopharma Reports Business Highlights and Financial..
31/10/202314:00GLOBELyell Immunopharma Presentations at SITC Highlight New..
27/9/202315:00GLOBELyell Immunopharma Announces the Acceptance of Six Abstracts..
11/9/202315:16EDGAR2Form 8-K - Current report
11/9/202314:00PRNUSCellares and Lyell to Evaluate Automated Manufacturing of..
31/8/202322:05GLOBELyell Immunopharma to Participate in Upcoming Investor..
08/8/202322:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:10EDGAR2Form 8-K - Current report
08/8/202322:05GLOBELyell Immunopharma Reports Business Highlights and Financial..
05/7/202322:05GLOBELyell Immunopharma Appoints Matthew Lang as Chief Business..
07/6/202322:05GLOBELyell Immunopharma to Participate in the Goldman Sachs..
Apertura: 2,44 Min: 2,35 Max: 2,66
Chiusura: 2,40

La tua Cronologia

NASDAQ
LYEL
Lyell Immunopharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network